Evidence map›Paper›PMID 38772919›Full record

ArticleDiabetologia2024

Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.

Danielle E Haslam, Liming Liang, Kai Guo, Marijulie Martínez-Lozano, Cynthia M Pérez, Chih-Hao Lee, Evangelia Morou-Bermudez, Clary Clish, David T W Wong, JoAnn E Manson and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Diabetologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Lifestyles, metabolome and diabetic kidney disease: a cohort study.QJM : monthly journal of the Association of Physicians · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Recent advances in precision nutrition and cardiometabolic diseases.Revista espanola de cardiologia (English ed.) · 2025
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Danielle E HaslamChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0144-3287
Liming LiangDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Kai GuoCenter for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Marijulie Martínez-LozanoCenter for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Cynthia M PérezDepartment of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Chih-Hao LeeDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Evangelia Morou-BermudezSchool of Dental Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Clary ClishBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
David T W WongCenter for Oral/Head and Neck Oncology Research, School of Dentistry, University of California Los Angeles, Los Angeles, CA, USA.
JoAnn E MansonChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Frank B HuChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Meir J StampferChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Kaumudi JoshipuraDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Shilpa N BhupathirajuChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. nhsnb@channing.harvard.edu.

Funding

Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI PORTER, JAMES T. · 2020 to 2024
$17.7M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Saliva and Plasma Metabolomic Signatures of Diabetes Progression in a Hispanic CohortR01DK120560 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI BHUPATHIRAJU, SHILPA NANDANA · 2019 to 2023
$2.3M
Proteomic and integrative omic profiles of sugar- and artificially sweetened beverage consumption and changes in type 2 diabetes risk factorsK01DK136968 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Danielle Haslam · 2023 to 2026
$634k
NCI NIH HHS T32 CA009001NCI NIH HHS T32CA009001NIDDK NIH HHS K01 DK136968NIDDK NIH HHS K01DK136968NIDDK NIH HHS R01 DK120560NIDDK NIH HHS R01DK120560NIGMS NIH HHS U54 GM133807
6 · The paper itself

Abstract

aims/hypothesisMany studies have examined the relationship between plasma metabolites and type 2 diabetes progression, but few have explored saliva and multi-fluid metabolites.

methodsWe used LC/MS to measure plasma (n=1051) and saliva (n=635) metabolites among Puerto Rican adults from the San Juan Overweight Adults Longitudinal Study. We used elastic net regression to identify plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting baseline HOMA-IR in a training set (n=509) and validated these scores in a testing set (n=340). We used multivariable Cox proportional hazards models to estimate HRs for the association of baseline metabolomic scores predicting insulin resistance with incident type 2 diabetes (n=54) and prediabetes (characterised by impaired glucose tolerance, impaired fasting glucose and/or high HbA

resultsPlasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance included highly weighted metabolites from fructose, tyrosine, lipid and amino acid metabolism. Each SD increase in the plasma (HR 1.99 [95% CI 1.18, 3.38]; p=0.01) and multi-fluid (1.80 [1.06, 3.07]; p=0.03) metabolomic scores was associated with higher risk of type 2 diabetes. The saliva metabolomic score was associated with incident prediabetes (1.48 [1.17, 1.86]; p=0.001). All three metabolomic scores were significantly associated with lower likelihood of regressing from prediabetes to normoglycaemia in models adjusting for adiposity (HRs 0.72 for plasma, 0.78 for saliva and 0.72 for multi-fluid), but associations were attenuated when adjusting for lipid and glycaemic measures. CONCLUSIONS/

interpretationThe plasma metabolomic score predicting insulin resistance was more strongly associated with incident type 2 diabetes than the saliva metabolomic score. Only the saliva metabolomic score was associated with incident prediabetes.

Indexed as

Diabetes Mellitus, Type 2Disease ProgressionInsulin ResistanceMetabolomicsPrediabetic StateSalivaAdultAgedFemaleHispanic or LatinoHumansLongitudinal StudiesMaleMiddle AgedPuerto RicoEpidemiologyInsulin sensitivity and resistanceMetabolomicsPrediction and prevention of type 2 diabetes

Identifiers

PMID38772919
PMCPMC12190488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.